Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Cara M. Rodgers"'
Autor:
Kevin J. Pridham, Zhi Sheng, Deborah F. Kelly, Renee Fajardin, Gary R Simonds, Sujuan Guo, Yanping Liang, Cara M. Rodgers, Lamvy Le, Sarah Algino, Robin T. Varghese
Publikováno v:
Neuro-Oncology. 20:494-505
Background Glioblastoma (GBM) is difficult to treat. Phosphoinositide 3-kinase (PI3K) is an attractive therapeutic target for GBM; however, targeting this pathway to effectively treat GBM is not successful because the roles of PI3K isoforms remain to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd65b12256cc686d54459e40b6ec60ad
https://doi.org/10.1093/neuonc/nox181
https://doi.org/10.1093/neuonc/nox181
Autor:
Pratik Kanabur, Sujuan Guo, Cara M. Rodgers, Gary R. Simonds, Deborah F. Kelly, Robert G. Gourdie, Scott S. Verbridge, Zhi Sheng
Publikováno v:
Oncotarget
// Pratik Kanabur 1, 3, * , Sujuan Guo 1, * , Cara M. Rodgers 7, * , Gary R. Simonds 7 , Deborah F. Kelly 1, 3, 4, 8 , Robert G. Gourdie 1, 4, 5, 6 , Scott S. Verbridge 5, Zhi Sheng 1, 2, 3, 4 1 Virginia Tech Carilion Research Institute, Roanoke, VA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b1b9da227aeb12b3de26a74910a05395
http://europepmc.org/articles/PMC5349922
http://europepmc.org/articles/PMC5349922
Autor:
Lamvy Le, Deborah F. Kelly, Robin T. Varghese, Gary R Simonds, Sujuan Guo, Zhi Sheng, Yanping Liang, Cara M. Rodgers, Kevin J. Pridham
Publikováno v:
Molecular Cancer Research. 18:A18-A18
The phosphatidylinositide 3-kinase (PI3K) family consists of four catalytic isoforms (PIK3CA, B, D, and G that encode p110alpha, beta, delta, and gamma, respectively), which play deviating roles in the formation and progression of different types of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::69a7a60dea72031a367dca9bc7d6614e
https://doi.org/10.1158/1557-3125.pi3k-mtor18-a18
https://doi.org/10.1158/1557-3125.pi3k-mtor18-a18
Autor:
Zhi Sheng, Cara M. Rodgers, Alyssa M. Osimani, Shaan Sharma, Samy Lamouille, Jane Jourdan, Robert G. Gourdie, Sujuan Guo, Robin T. Varghese, Gary R Simonds, Kevin J. Pridham, Susan Murphy, Pratik Kanabur
Resistance of glioblastoma (GBM) to the front-line chemotherapeutic agent temozolomide (TMZ) continues to challenge GBM treatment efforts. The repair of TMZ-induced DNA damage by O-6-methylguanine-DNA methyltransferase (MGMT) confers one mechanism of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23bac444b9ce6ca93cc99f19dfaf41c3
https://europepmc.org/articles/PMC5113032/
https://europepmc.org/articles/PMC5113032/
